Inhibikase Therapeutics, Inc.
IKT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$27,520 | -$19,029 | -$18,054 | -$14,786 |
| Dep. & Amort. | $26 | $177 | $7 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $8,141 | $500 | $458 | $1,532 |
| Change in WC | $205 | $235 | $171 | -$1,764 |
| Other Non-Cash | $0 | $32 | $67 | $722 |
| Operating Cash Flow | -$19,148 | -$18,085 | -$17,351 | -$14,297 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$14 | -$243 | $0 |
| Net Acquisitions | $0 | $0 | $243 | $0 |
| Inv. Purchases | -$60,455 | -$29,426 | -$20,725 | $0 |
| Inv. Sales/Matur. | $23,451 | $41,097 | $4,963 | $0 |
| Other Inv. Act. | $0 | $0 | -$243 | $0 |
| Investing Cash Flow | -$37,004 | $11,657 | -$16,006 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$249 | -$43 |
| Stock Issued | $103,478 | $8,544 | $44 | $41,135 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$139 | $0 | $1 |
| Financing Cash Flow | $103,478 | $8,405 | -$205 | $41,094 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $47,325 | $1,977 | -$33,562 | $26,797 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $9,165 | $7,189 | $40,750 | $13,954 |
| End Cash | $56,491 | $9,165 | $7,189 | $40,750 |
| Free Cash Flow | -$19,148 | -$18,099 | -$17,594 | -$14,297 |